Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its "underperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $7.00 price target on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com